Related Experiment Videos
Use of mitomycin C for maintaining myringotomy patency
1Division of Otolaryngology, Department of Surgery, University of Missouri School of Medicine, Columbia, USA.
Summary
Topical mitomycin C significantly prolonged the patency of chick myringotomy sites without ventilation tubes. This antineoplastic agent offers potential for maintaining open surgical sites in otologic procedures.
Area of Science:
- Otolaryngology
- Ophthalmology
- Pharmacology
Background:
- Myringotomy sites typically close rapidly without ventilation tubes.
- Mitomycin C is an antineoplastic agent known to prolong surgical site patency, notably in glaucoma surgery.
- Maintaining myringotomy patency is crucial for certain otologic interventions.
Purpose of the Study:
- To investigate the efficacy of topical mitomycin C in prolonging myringotomy patency in chicks.
- To assess if mitomycin C can maintain an open myringotomy without the need for a ventilation tube.
Main Methods:
- Bilateral myringotomies (0.4 mm) were created using a KTP laser in 28 chicks.
- Mitomycin C was applied to experimental ears; sterile water served as the control.
- Chicks were divided into groups receiving fresh or 2-week-old mitomycin C.
Main Results:
- Experimental myringotomy patency rates were 80% (fresh) and 70% (2-week-old) at 15 days, versus 33% and 7.7% at 30 days.
- Control myringotomy sites healed within 5 days.
- Logistic regression showed a significant odds ratio of 149.1 (P=0.0001) for mitomycin C prolonging patency.
Conclusions:
- Topical mitomycin C significantly prolongs the patency of myringotomy sites in chick tympanic membranes.
- The findings suggest a potential role for mitomycin C in preventing premature closure of myringotomies.
- Further research may explore clinical applications in otologic surgery.